| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | sarcosine | 0.4471 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.4622 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.4776 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.4851 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.5262 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.5441 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.5598 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.5710 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.5812 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6091 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6252 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6599 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6601 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6634 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6638 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6643 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6709 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6745 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6770 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6777 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6933 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.6988 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7089 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7133 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7176 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7195 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7265 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7275 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7317 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7329 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7387 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7431 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7489 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7543 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7554 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7620 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7632 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7801 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.7812 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8030 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8047 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8069 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8081 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8096 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8100 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8142 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8142 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8221 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8221 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8245 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8251 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8357 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8381 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8407 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8508 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8547 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8596 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8609 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8692 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8714 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8796 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8811 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8917 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8920 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.8922 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9001 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9025 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9110 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9155 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9157 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9210 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9291 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9314 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9387 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9427 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9523 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9587 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9588 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9599 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9637 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9659 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9684 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9752 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9771 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9772 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9812 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9818 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9818 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9824 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9827 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9852 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9865 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 0.9967 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0000 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0033 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0080 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0224 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0240 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0255 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0295 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0372 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0447 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0508 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0561 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0664 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0666 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0687 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0688 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0714 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0744 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0751 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0763 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0788 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0796 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0919 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0977 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.0995 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1023 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1160 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1161 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1348 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1418 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1419 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1427 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1465 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1511 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1522 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1530 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1647 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1733 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1837 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1839 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.1850 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2026 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2059 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2078 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2100 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2111 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2111 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2233 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2388 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2457 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2484 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2514 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2740 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2864 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2872 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2893 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.2999 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3014 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3205 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3258 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3273 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3360 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3406 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3458 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3625 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3673 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3823 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3864 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.3903 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.4063 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.4228 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.4341 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.4381 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.4429 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.4461 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5114 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5206 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5214 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5499 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5545 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5725 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5890 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.5893 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.6101 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.6297 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.6520 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.6786 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.6959 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.6974 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.7301 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.8216 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.8305 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 1.9011 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 2.2416 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | sarcosine | 2.4664 | scaled units | Placebo | +23HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|